CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD
- Country
- France
- Type
- Beneficiary
- Website
- www.centreleonberard.fr
- Grants received
- 18
Funding record
- 18 grants on record
- €7,234,618.65 awarded in total
- 2009–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
7 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
- INSTITUT CURIE
- INSTITUT GUSTAVE ROUSSY
- ST ANNA KINDERKREBSFORSCHUNG VEREIN
- THE UNIVERSITY OF MANCHESTER
Calls from this organisation
No published calls from this organisation.
Grants received
- UPright radiotherapy: Learning, Innovation, Fellowship and Training
- A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES
- THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER
- Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers
- Proton versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
- European Rare dIsease research Coordination and support Action
- Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management
- Integrated and standardized NGS workflows for Personalised therapy
- Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network
- European Joint Programme on Rare Diseases
- A drug strategy targeting heat shock protein 90 to combat metastatic, p53 mutant ovarian cancer.
- EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma
- Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers
- First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept
- EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.